Calyxt is a plant-based synthetic biology company that utilizes its proprietary PlantSpring technology platform to engineer plant metabolism to produce materials and products. Co. is focused on developing synthetic biology solutions through its PlantSpring technology platform for manufacture using its proprietary and differentiated BioFactory production system across a range of end markets, including the cosmeceutical, nutraceutical, and pharmaceutical industries. Co. also out-licenses elements of the PlantSpring technology platform and may selectively develop products in agriculture. Co.'s product, an improved digestibility alfalfa, was developed with and licensed to S&W Seed Company. The CLXT average annual return since 2017 is shown above.
The Average Annual Return on the CLXT average annual return since 2017 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether CLXT average annual return since 2017 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the CLXT average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|